Wartmann, T
National Consensus on Semaglutide in Cardiology: From Clinical Evidence to Clinical Translation
Finally, in both study cohorts, we matched combination users in chronological order, in a one to one ratio without replacement, to GLP-1 receptor agonist or SGLT-2 inhibitor users (depending on the cohort) with the same background drug, duration of use of the background drug, and propensity score
Monitoring and Support - Throughout your GLP-1 treatments, our team will closely monitor your progress, conduct regular follow-ups, and make adjustments as necessary
Electrolyte drinks are leading the charge, followed by flavoured water, functional beverages with bioactive ingredients and convenient formats like ready-to-mix powders and effervescent tablets